Tekcapital plc Directorate Change (1142F)
10 11월 2015 - 4:01PM
UK Regulatory
TIDMTEK
RNS Number : 1142F
Tekcapital plc
10 November 2015
Tekcapital plc
("Tekcapital" or the "Company")
Appointment of Non-Executive Director and Grant of Options
Tekcapital plc (AIM: TEK), an international provider of
technology and intellectual property services, announces that
Robert Clell Miller, M.D., has been appointed to the Company's
Board as a Non-Executive Director with immediate effect.
Dr. Miller is Vice Chairman of the Board of Trustees of Mayo
Clinic Health System - Albert Lea and Austin.
Dr. Miller is also a Professor of Radiation Oncology at Mayo
Clinic Jacksonville and is also Medical Director of Mayo Clinic's
Operations in Northfield. Dr. Miller has over 20 years' experience
in Radiation Oncology and is currently Editor in Chief of the Rare
Tumours medical journal in Italy and the Advances in Radiation
Oncology medical journal in the USA.
In addition to a medical degree from the University of Kentucky,
Dr. Miller has undergraduate degrees in Business Administration and
Engineering Physics from the University of Tulsa, a master's degree
in Radiological Medical Physics from the University of Kentucky and
an MBA from the University of Oxford, UK.
Clifford M. Gross, Executive Chairman of Tekcapital, said: "We
are delighted to add Dr. Miller to the Board and believe his
addition will provide significant business, medical and scientific
expertise for future evaluations of medical technology and their
opportunities for industrial scale commercialisation".
Additional information regarding Dr Robert Miller
Dr Robert Clell Miller, aged 52, is, or has been a director or
partner of the following companies or partnerships during the past
five years:
Current Directorships and Partnerships: Directorships and Partnerships
held in the previous 5 years:
Mayo Clinic Health System - Albert None
Lea and Austin
Grant of Options
Tekcapital also announces the grant of 120,000 options to
subscribe for new ordinary shares of 0.4 pence each in the Company
("Ordinary Shares") (the "Options") to Dr Miller on 10 November
2015 (the "Grant Date"), in connection with his appointment. These
Options have an exercise price of 45.5 p per share, being the
closing mid-market price of Ordinary Shares on 9 November 2015. The
Options vest over a three year period as to one third on the first
anniversary, one third on the second anniversary and one third on
the third anniversary of the Grant Date. All Options granted will
vest immediately if the mid-price of Ordinary Shares is maintained
at or above GBP1.00 for ten consecutive trading days. The Options
have been granted under the Company's non-EMI share option plan and
will expire on the fifth anniversary of the Grant Date.
The Options represent 0.34% of the Company's current issued
ordinary share capital. Following the grant of the Options, the
total number of options outstanding to subscribe for new Ordinary
Shares in the Company is 2,510,000, representing 7.22% of the
Company's current issued ordinary share capital.
For further information please contact:
Tekcapital Plc +1 305 200 3450 Ext 305
Clifford M. Gross info@tekcapital.com
Allenby Capital Limited (Nominated Adviser
& Joint Broker) +44 (0)20 3328 5656
Jeremy Porter / Alex Brearley
Optiva Securities Limited (Joint Broker) +44 (0) 20 3137 1904
Jeremy King / Vishal Balasingham jeremy.king@optivasecurities.com
Walbrook PR Ltd +44 (0) 20 7933 8780
Paul Cornelius / Paul McManus tekcapital@walbrookpr.com
Tekcapital plc - The World's Largest University Network for Open
Innovation
Tekcapital helps clients profit from new, university-developed
intellectual properties. With our proprietary discovery search
engine, linked to 4,000+ universities in 160 countries, coupled
with expert scientific review, we provide a turn-key service to
make it easy for clients to find and acquire the IP they need to
create a competitive advantage. Tekcapital plc is listed on the AIM
market of the London Stock Exchange (AIM: symbol TEK) and is
headquartered in Oxford, in the UK. For more information, please
visit www.tekcapital.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
BOAPKCDPDBDBQDK
(END) Dow Jones Newswires
November 10, 2015 02:01 ET (07:01 GMT)
Tekcapital (LSE:TEK)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024
Tekcapital (LSE:TEK)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024